Valneva SE (VALN) Receivables - Net (2020 - 2026)

Valneva SE (VALN) posted quarterly Receivables - Net of $11.5 million for Q1 2026, down 69.78% year-on-year from $38.1 million in Q1 2025, and down 63.57% on a QoQ basis from $31.6 million in Q4 2025.

Valneva SE (VALN) Receivables - Net (2020 - 2026) Analysis & Trends

Valneva SE (VALN) has reported Receivables - Net for 7 consecutive years, with $11.5 million the latest figure, recorded in Q1 2026.

  • Quarterly Receivables - Net fell 69.78% year-over-year to $11.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.5 million (down 69.78% YoY) and the FY2025 annual result came in at $31.6 million, down 21.0% from the prior year.
  • Receivables - Net declined to $11.5 million in Q1 2026 per VALN's latest filing, from $31.6 million in the prior quarter.
  • Over the last five years, Receivables - Net for VALN reached as high as $65.7 million in Q3 2022 and fell as low as $11.5 million in Q1 2026.
  • A 5-year average of $34.1 million and a median of $31.6 million in 2025 frame the typical range for Receivables - Net.
  • Annual changes were most pronounced in 2023 — Receivables - Net soared 107.93% — and 2026, when it plunged 69.78%.
  • Year by year, Receivables - Net stood at $27.3 million in 2022, then surged by 73.54% to $47.4 million in 2023, then dropped by 15.46% to $40.1 million in 2024, then declined by 21.0% to $31.6 million in 2025, then slumped by 63.57% to $11.5 million in 2026.
  • According to Business Quant data, Receivables - Net over the past three periods registered $11.5 million, $31.6 million, and $22.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Valneva SE 803.90 Mn 680.66 Mn 5.38 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 11.53 Mn
Mar 31, 2026 11.53 Mn
Dec 31, 2025 31.65 Mn
Dec 31, 2025 31.65 Mn
Sep 30, 2025 22.85 Mn
Sep 30, 2025 22.85 Mn
Jun 30, 2025 27.45 Mn
Jun 30, 2025 27.45 Mn
Mar 31, 2025 38.15 Mn
Mar 31, 2025 38.15 Mn
Dec 31, 2024 40.06 Mn
Dec 31, 2024 40.06 Mn
Sep 30, 2024 34.55 Mn
Sep 30, 2024 34.55 Mn
Jun 30, 2024 34.81 Mn
Jun 30, 2024 34.81 Mn
Mar 31, 2024 31.05 Mn
Mar 31, 2024 31.05 Mn
Dec 31, 2023 47.39 Mn
Dec 31, 2023 47.39 Mn